| 5th Oct 2016 5:10 pm |
RNS |
Notification of Major Interest in Shares |
| 26th Sep 2016 3:59 pm |
RNS |
Director Dealing |
| 21st Sep 2016 11:27 am |
RNS |
Raises £8.0 M through a Placing and Subscription |
| 20th Sep 2016 7:00 am |
RNS |
Proposed Placing & Subscription to raise £8M |
| 5th Sep 2016 7:00 am |
RNS |
Interim Results for six months ended 30 June 2016 |
| 10th Aug 2016 7:00 am |
RNS |
Faron Pharmaceuticals Notice of Interim Results |
| 25th Jul 2016 7:00 am |
RNS |
Faron enters agreement with Abzena for Clevegen |
| 22nd Jun 2016 12:00 pm |
RNS |
Faron to Present at Proactive Investors Forum |
| 14th Jun 2016 7:00 am |
RNS |
Faron Provides Update at R&D Day |
| 13th Jun 2016 7:00 am |
RNS |
Faron Licenses Traumakine Rights to Pharmbio Korea |
| 26th May 2016 10:53 am |
RNS |
Faron Result of Annual General Meeting |
| 26th May 2016 7:00 am |
RNS |
Faron Expands R&D Strategy for Clevegen |
| 13th May 2016 7:00 am |
RNS |
Faron Pharmaceuticals Ltd to host an R&D Day |
| 4th May 2016 7:00 am |
RNS |
Notice of AGM |
| 3rd May 2016 7:00 am |
RNS |
Faron Appoints New Medical Director |
| 22nd Apr 2016 7:00 am |
RNS |
Faron Appoints Panmure Gordon as Joint Broker |
| 19th Apr 2016 7:00 am |
RNS |
Faron Files Two New Patents to Protect Clevegen |
| 10th Mar 2016 7:00 am |
RNS |
Annual Results for the year ended 31 December 2015 |
| 1st Mar 2016 7:00 am |
RNS |
Faron files patent application for Traumakine |
| 10th Feb 2016 7:00 am |
RNS |
Notice of Preliminary Results |
| 7th Jan 2016 7:00 am |
RNS |
Top-line results from Japanese study of Traumakine |
| 29th Dec 2015 7:00 am |
RNS |
First Patient recruited in Phase III ARDS Study |
| 21st Dec 2015 7:00 am |
RNS |
Faron Awarded ?1.5 million Tekes Funding |
| 30th Nov 2015 7:00 am |
RNS |
Key Publication in Journal of Immunology |
| 17th Nov 2015 7:30 am |
RNS |
Admission to AIM and first day of dealings |
